08.15.23
A supplement which contains a blend of fruit antioxidants marketed by Advance Pharmaceutical Inc. as Revivify was evidenced to be effective in reducing Acne vulgaris in an unpublished study conducted by researchers at Texas A&M University School of Medicine, in conjunction with Orion Institute for Translational Medicine and Praava Health.
Among other causes, most acne appears due to an overproduction of sebum by the sebaceous gland, leading to clogged hair follicles, bacterial accumulation and other complications.
Revivify, a blend of superoxide dismutase, prebiotic fiber, and polyphenols from a variety of sources, is formulated to support innate immune and inflammatory processes through antioxidant activity. It was tested in 20 acne patients based in Bangladesh in order to assess its potential benefit in acne, uneven skin tone, post-inflammatory hyperpigmentation, and scarring.
In the study, the control group received oral doxycycline and topical therapy, whereas the experimental group received Revivify along with the same therapies administered to the control group, in order to see how supplementation might enhance the benefits of typical acne therapy.
The Revivify group saw significantly greater reductions in blemishes, inflammatory marker levels, and post-inflammatory effects like hyperpigmentation and scars, compared to the controls.
However, more large-scale data is needed in order to better establish the efficacy of this product in treating acne, the authors concluded.
Among other causes, most acne appears due to an overproduction of sebum by the sebaceous gland, leading to clogged hair follicles, bacterial accumulation and other complications.
Revivify, a blend of superoxide dismutase, prebiotic fiber, and polyphenols from a variety of sources, is formulated to support innate immune and inflammatory processes through antioxidant activity. It was tested in 20 acne patients based in Bangladesh in order to assess its potential benefit in acne, uneven skin tone, post-inflammatory hyperpigmentation, and scarring.
In the study, the control group received oral doxycycline and topical therapy, whereas the experimental group received Revivify along with the same therapies administered to the control group, in order to see how supplementation might enhance the benefits of typical acne therapy.
The Revivify group saw significantly greater reductions in blemishes, inflammatory marker levels, and post-inflammatory effects like hyperpigmentation and scars, compared to the controls.
However, more large-scale data is needed in order to better establish the efficacy of this product in treating acne, the authors concluded.
